日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

一种首创的泛赖氨酰氧化酶抑制剂可抑制基质重塑,并增强吉西他滨对胰腺癌的疗效和生存率。

Jessica L Chitty,Michelle Yam #,Lara Perryman #,Amelia L Parker,Joanna N Skhinas,Yordanos F I Setargew,Ellie T Y Mok,Emmi Tran,Rhiannon D Grant,Sharissa L Latham ,Brooke A Pereira ,Shona C Ritchie,Kendelle J Murphy ,Michael Trpceski ,Alison D Findlay,Pauline Melenec,Elysse C Filipe,Audrey Nadalini,Sipiththa Velayuthar,Gretel Major,Kaitlin Wyllie,Michael Papanicolaou,Shivanjali Ratnaseelan,Phoebe A Phillips,George Sharbeen,Janet Youkhana,Alice Russo,Antonia Blackwell,Jordan F Hastings,Morghan C Lucas,Cecilia R Chambers,Daniel A Reed,Janett Stoehr,Claire Vennin,Ruth Pidsley ,Anaiis Zaratzian,Andrew M Da Silva,Michael Tayao,Brett Charlton,David Herrmann,Max Nobis ,Susan J Clark ,Andrew V Biankin ,Amber L Johns,David R Croucher ,Adnan Nagrial,Anthony J Gill   ,Sean M Grimmond  ; Australian Pancreatic Cancer Genome Initiative (APGI); Australian Pancreatic Cancer Matrix Atlas (APMA); Marina Pajic ,Paul Timpson,Wolfgang Jarolimek,Thomas R Cox

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis

赖氨酰氧化酶类 2/3 酶抑制剂 PXS-5153A 可减少交联并改善纤维化

Heidi Schilter, Alison D Findlay, Lara Perryman, Tin T Yow, Joshua Moses, Amna Zahoor, Craig I Turner, Mandar Deodhar, Jonathan S Foot, Wenbin Zhou, Angelique Greco, Amar Joshi, Benjamin Rayner, Sarah Townsend, Alberto Buson, Wolfgang Jarolimek

The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase

缺氧癌症分泌蛋白组通过赖氨酰氧化酶诱导转移前骨病变

Thomas R Cox, Robin M H Rumney, Erwin M Schoof, Lara Perryman, Anette M Høye, Ankita Agrawal, Demelza Bird, Norain Ab Latif, Hamish Forrest, Holly R Evans, Iain D Huggins, Georgina Lang, Rune Linding, Alison Gartland #, Janine T Erler #

Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition

在可通过特异性受体抑制靶向的原位异种移植模型中,Wilms 肿瘤细胞对胰岛素样生长因子 1 信号传导的依赖性

Aleksandra Bielen, Gary Box, Lara Perryman, Lynn Bjerke, Sergey Popov, Yann Jamin, Alexa Jury, Melanie Valenti, Alexis de Haven Brandon, Vanessa Martins, Vincent Romanet, Sebastien Jeay, Florence I Raynaud, Francesco Hofmann, Simon P Robinson, Suzanne A Eccles, Chris Jones

EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines

儿童高级别胶质瘤的 EGFRvIII 缺失突变及儿童胶质瘤细胞系对靶向治疗的反应

Dorine A Bax, Nathalie Gaspar, Suzanne E Little, Lynley Marshall, Lara Perryman, Marie Regairaz, Marta Viana-Pereira, Raisa Vuononvirta, Swee Y Sharp, Jorge S Reis-Filho, João N Stávale, Safa Al-Sarraj, Rui M Reis, Gilles Vassal, Andrew D J Pearson, Darren Hargrave, David W Ellison, Paul Workman, Ch